The Impact of Conjugation Mode and Site on Tubulysin Antibody‐Drug‐Conjugate Efficacy and Stability
Authors:
Open Access
- 28 May 2025
- journal article
- Published by Wiley in ChemistryOpen
- Vol. 14 (8) , e2400522
Abstract
Antibody‐drug conjugates (ADCs) represent a prominent class of biotherapeutics engineered to selectively deliver cytotoxic payloads to tumors, thereby facilitating targeted cell killing. While first‐generation ADCs, created by conjugating payloads to surface‐accessible lysine or hinge‐cysteine residues, have achieved clinical success, several site‐specific ADCs with defined drug‐to‐antibody ratios are currently under clinical investigation. Herein, the efficacy, stability, and pharmacokinetics of ADCs generated by attaching the drug linker to surface‐exposed lysine residues, hinge‐cysteine residues, and the C’E loop in the CH2 domain (mediated by bacterial transglutaminase) using a tubulysin payload are compared. In N87 xenograft mice, the order of efficacy is C’E loop > hinge‐cysteine > lysine‐conjugated ADCs. Among the three ADCs evaluated, the site‐specific ADC demonstrates superior in vivo stability (minimal payload‐linker deconjugation and limited payload metabolism/deacetylation) and favorable pharmacokinetics (longer half‐life, low clearance, high exposure). In contrast, the lysine‐conjugated ADC exhibits the least stability and poorest pharmacokinetics, which directly correlate with its efficacy. Further investigation into cysteine‐engineered site‐specific ADCs with payloads conjugated at various sites confirms that both the conjugation chemistry and the site of conjugation significantly influence the in vivo stability and pharmacokinetics of site‐specific ADCs.Keywords
This publication has 39 references indexed in Scilit:
- Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and N-Glycosylated AntibodiesBioconjugate Chemistry, 2022
- Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug ConjugatesJournal of Pharmaceutical Sciences, 2021
- Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical StudiesAnalytical Chemistry, 2019
- Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody–Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine ConjugationBioconjugate Chemistry, 2019
- Minireview: Addressing the retro-Michael instability of maleimide bioconjugatesDrug Discovery Today: Technologies, 2018
- Advances in antibody–drug conjugates: A new era of targeted cancer therapyDrug Discovery Today, 2017
- Attachment Site Cysteine Thiol pKa Is a Key Driver for Site-Dependent Stability of THIOMAB Antibody–Drug ConjugatesBioconjugate Chemistry, 2017
- Antibody-drug conjugates: recent advances in conjugation and linker chemistriesProtein & Cell, 2016
- Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug ConjugatesChemistry & Biology, 2013
- Site‐Specific and Stoichiometric Modification of Antibodies by Bacterial TransglutaminaseAngewandte Chemie International Edition, 2010